|
ABOUT
NATRECIA
Natrecia
- A Natural Supplement
formulated by
Dr. Razack for Treating Androgenic Alopecia and
benign prostate
enlargement or Benign Prostatic Hyperplasia
Natrecia is a food supplement composed of minerals,
vitamins and herbs. Its intended use is for hair health and
maintenance. It can also be used for treatment of benign
prostatic hyperplasia (BPH), the swelling of the prostate in
middle-aged men. Natrecia will benefit both men and women.
People who use Natrecia can also use our topical hair
maintenance product, Crinagen. The components of Natrecia are:
(per tablet).
Saw Palmetto Berries
Extract 400 mg; Beta Sitosterol 200 mg; Rye Pollen
Extract 100 mg;
Pumpkin Seed Extract 100 mg; Lycopene 50 mg; Zinc 20 mg;Copper 1
mg; Vitamin B6 (pyridoxal-5-phosphate) 10 mg; Phosphorus (as
phosphate) 100 mg;
Calcium 125 mg
The new Natrecia
(released in September, 2003) is in the form of a
large tablet and
it contains substantially more saw palmetto content. Some people
find it difficult to swallow. However, chewing
very easily
crushes the tablet. If chewed, it has a bitter taste due to
the zinc content.
So, taking it with fruit juice or food is recommended.
The tiny blue
specks on and inside the tablets are the copper oxide. The
small white lumps
on some tablets are normal. This was a very difficult
tablet to
compress because of the large amount of saw palmetto it
contains.
Natrecia is a completely natural, vitamin, mineral, and
herbal supplement specifically developed for combating the
effects of androgenic alopecia (AP) (i.e., male-pattern
baldness). Its formulation is based on a significant body of
research that firmly establishes the effect that certain natural
agents have in combating the effects of dihydrotestosterone (DHT)
in the treatment of benign prostatic hyperplasia (BPH).
This essay begins with a detailed discussion of the
prostate gland because prostatic disease has a similar hormonal
etiology to androgenic alopecia (male pattern hair loss). Both
conditions are caused, in part, by the male sex hormone
dihydrotestosterone (DHT). Most importantly, both conditions are
preventable.
The prostate is a gland located beneath the urinary
bladder in men. It is responsible for the production of fluids
involved in reproduction. When men urinate, the urine that is
stored in the bladder must travel through a conduit, called the
urethra, before it can exit the penis. The urethra passes
through the prostate after exiting the bladder. This is because
in addition to carrying urine, the urethra is also responsible
for carrying the reproductive fluids that are produced in the
prostate. As a consequence of its location, an enlarged prostate
can contribute to urinary flow obstruction as well as to bladder
dysfunction by "squeezing" on the urethra. This can result in
the various urinary symptoms associated with an enlarged
prostate, such as frequent urination during the day, frequent
urination at night, dribbling, having a weak urinary stream,
urgency, and incomplete emptying of the bladder. It can also
result in the inability to urinate altogether.
The medical term for a non-cancerous enlarged prostate
is benign prostatic hyperplasia. The somewhat similar term,
benign prostatic hypertrophy, is commonly used. Again, this
condition is thought to result, in part, from exposure to
specific androgens, such as dihydrotestosterone. Autopsy results
reveal that virtually all men who live past a certain age
develop this condition. Individuals born with a deficiency in
5-alpha reductase, the enzyme that produces dihydrotestosterone,
suffer neither hair loss nor prostatic disease. People who lack
this enzyme are unable to produce the more potent form of
testosterone, dihydrotestosterone. Again, dihydrotestosterone
(DHT) is required for the development of both androgenic
alopecia (male pattern hair loss) and prostatic disease (BPH).
There are two basic treatment options for an enlarged
prostate gland or benign prostatic hyperplasia. These include
medical (drugs) and surgical therapy. When men with benign
prostatic hyperplasia, a condition many physicians believe to be
caused by excess dihydrotestosterone, were treated with oral or
systemic finasteride (the generic name of Propecia and Proscar),
their enlarged prostate glands became smaller [1].
Unfortunately, this study also revealed that a small percentage
of the patients (less than 6%) receiving this drug also suffered
from sexually related side effects such as decreased sex drive
and impotence [1]. Surgical therapy can also lead to sexually
related side effects.
Recently, medical literature has provided increased
support for the use of naturally occurring nutrients that
prevent the progressive enlargement of the prostate gland (BPH).
Some of these nutrients have even been shown to reduce the
incidence of prostate cancer! The nutrients that combat the
detrimental effects of DHT in the prostate can be utilized to
combat the effects of DHT in hair loss. The following discussion
outlines multiple DHT-fighting agents. Each of these agents is
included in Natrecia.
This is by far the most commonly recognized and
discussed herb concerning the prostate. Before we even begin its
discussion, I highly recommend reading the book entitled "Saw
Palmetto: Nature's Prostate Healer" by Ray Sahelian, M.D. This
is a marvelous book that discusses the prostate and how Saw
palmetto and other natural nutrients can prevent prostate
disease (BPH).
Saw palmetto is a plant (dwarf palm tree) native to the
United States. It has been used medicinally for over a century.
Its first use was described in the medical literature in the
1800s. Early literature concerning Saw palmetto stated that it
relieved symptoms ranging from prostate enlargement in men to
gynecological problems in women, such as menstrual discomfort.
It has even been described as a potential aphrodisiac.
Saw palmetto contains hundreds of different substances
that can account for its beneficial effects. Saw palmetto is
usually distributed as a crushed berry or as an extract. The
extract form contains most of the substances found to be
effective in treating benign prostatic enlargement. The extract
form has been shown to be more potent than the dried berry form.
The extract, then, is the form of choice.
There are many articles in the medical literature that
establish the efficacy of Saw palmetto in treating benign
prostatic hyperplasia. One of the most recent and prestigious
articles is "Saw Palmetto Extracts for the Treatment of Benign
Prostatic Hyperplasia: a Systematic Review" by Timothy J. Wilt,
MD, MPH et al. It appeared in The Journal of the American
Medical Association on November 11, 1998 [2]. The study clearly
demonstrated that the use of Saw palmetto improved urinary tract
symptoms associated with benign prostatic hyperplasia. It also
demonstrated that Saw palmetto provided similar improvement in
urinary tract symptoms when compared to drugs such as
finasteride. Saw palmetto was associated with fewer side
effects. Although the mean study duration (the period of time
that participants were using Saw palmetto) was 9 weeks,
participants were noticing positive results in as little as 4
weeks. Finasteride users commonly saw relief of symptoms after
three months.
The next three paragraphs are a bit technical, but some
readers may appreciate the detail. Others may wish to skip ahead
to the paragraph that begins, “It is clear that….”
A total of 18 randomized controlled trials involving
2939 men who met inclusion criteria were analyzed. Treatment
allocation concealment was adequate in 9 studies (i.e., they
were single-blind tests), whereas 16 studies were
double-blinded. The average duration of the study was 9 weeks.
In comparison to the men in the placebo control group, men
treated with the SP extract Serenoa repens (S. repens or Saw
palmetto) showed a measurable improvement in urinary tract
symptoms. The weighted average difference for patients treated
with S. repens was -1.41 points with a 95% confidence interval
of L2.52, -0.301, compared to the control group's weighted-mean
difference of -0.76 with a 95% confidence interval of [-1.22,
-0.32]. This represents a relative weighted mean difference of
46% (Here, a lower weighted-mean difference correlates with
improved urinary tract function). The patients themselves
provided self-improvement ratings in urinary tract symptoms that
were highly correlated with their quantitative evaluations.
Compared with men receiving finasteride, men treated
with S. repens showed similar improvements in urinary tract
scores. The main advantage of treatment of BPH with S. repens
over finasteride was apparent in the decreased incidence of
adverse side effects. For example, 4.9% of patients treated with
finasteride reported erectile dysfunction compared with 1.1% of
patients treated with S. repens. These percentages are based on
the Neyman-Pearson binary hypothesis test with power function
parameter P set to P<0.001. That is, the probability of a
Type-II error was fixed at 0.999. Here, a Type-II error refers
to the probability of accepting the null hypothesis H_0 (no
urinary tract improvement) when the alternative hypothesis H_1
(urinary tract improvement) is actually true. The significance
level for all randomized trials was set at 0.05, thus indicating
a probability of 0.05 of rejecting H_0 when H_1 is true.
Some key points regarding these results are in order
here. First, since all the statistical studies are based on
classical (or frequentist) methods, all inferences derived from
them are inherently indirect. That is, no direct claims can be
made regarding the probabilities of improved urinary tract
function. Rather, one can only infer the probabilities that the
treatment did not fail. This is by no means a fallacy, neither
on the part of the researchers nor on the methods of data
acquisition, but is an inherent aspect of frequentist analysis.
To emphasize this point further, consider the value of the
mean-weighted difference for patients treated with S. repens.
The reported value was -1.41. Note that this is not a true
statistical estimate of this parameter. Rather, it is a measured
value that has a 95% probability of being contained in the
random interval [2.52,-0.30]. If one wished to make direct
inferences from the data, non-classical statistical analyses,
such as those based on Bayesian decision theory, should be
employed [3]. Another point worth mentioning concerns the
sensitivities of the tests. Since the studies did not report the
standard errors of the differences between the means of S.
repens and control, the authors assessed the sensitivity of the
tests by analyzing data for three different values of
correlation coefficients, namely (0.25, 0.50, 0.75). The work,
then, reported "no significant statistical difference in
outcomes according to the three correlation coefficients." As a
result, the correlation coefficient was arbitrarily set to 0.50.
One could certainly argue that this is a somewhat ad-hoc
approach. To be more precise and more objective, the correlation
coefficient could have (and should have) been estimated by a
standard technique such as the method of maximum likelihood [4]
or via another point estimator such as the Bayesian minimum mean
square error (MMSE) estimator or even the Bayesian maximum
a-posteriori (MAP) estimator [5]. This would certainly have
altered the calculated relative weighted mean difference from
its reported value of 46%, but to what degree is unknown. Note
that the relative weighted mean difference of 46% was not
actually reported in the JAMA article [1] but rather was
calculated by the current authors based on the results in [1].
It is clear that there was an improvement in patients
given Saw palmetto over the placebo-control group, and,
moreover, the improved urinary tract function paralleled that
which was displayed by patients taking finasteride. This study
clearly demonstrated that the use of Saw palmetto improved
urinary tract symptoms associated with BPH, and that its effects
were in concert with the improvements achieved through the use
of finasteride. It was also shown that, compared to finasteride,
Saw palmetto administration produced a lower incidence of
adverse side effects. The mean duration of the study encompassed
9 weeks of Saw palmetto administration. However, many
participants were reporting positive results in as little as 4
weeks.
Both Saw palmetto and finasteride were found to be
effective in the treatment of benign prostatic hyperplasia (BPH).
This study clearly establishes the role of Saw palmetto in
combating the effects of DHT. Note that Saw palmetto was
compared to 5 mg of finasteride in this study and that Propecia
contains only 1 mg of finasteride.
Side effects experienced with Saw palmetto are
infrequent. One three-year study with 315 patients showed that
98% of the patient population had no significant side effects
[6]. The most common side effects experienced with Saw palmetto
include nausea and mild headache. Since Saw palmetto is
fat-soluble, it is better to take it with meals. It usually
takes one to two hours to be absorbed.
References (relating to Saw palmetto):
1. Gormley GJ, et al. The effect of finasteride in men
with benign prostatic hyperplasia. N Engl J
Med;327:1185-1191,1992.
2. T.J. Wilt, A. Ishani, G. Stark, R. MacDonald, J.
Lau, and C. Muirow. Saw Palmetto extracts for treatment of
benign prostatic hyperplasia. JAMA;280(18)1604-1609, 1998.
3. J. O'Berger, Statistical Decision Theory and
Bayesian Analysis, 2nd Ed., Springer Verlag Series in
Statistics, Springer,1985.
4. PJ. Bickel and K.A. Doksum, Mathematical Statistics
-- Basic Ideas and Selected Topics, Prentice Hall, Englewood
Cliffs, NJ, 1977.
5. A. O'Hagan, Kendall's Advanced Theory of Statistics,
Volume 2B: Bayesian Inference, Halsted Press, New York, 1994.
6. D. Authie and J. Cauquil. A multicenter study of the
efficacy of Permixon in daily practice. Pharmacol Clin;
5(56):3-13, 1987.
Suggested Reading: For the section above and all
sections below, there is excellent reading in this book:
Sahelian, R.; Saw Palmetto: Nature's Prostate Healer; New York;
Kensington Publishing Company, 1998.
Pygeum africanum is an evergreen tree indigenous to
Africa. Extracts from its bark have been shown to improve
urinary tract symptoms associated with benign prostatic
hyperplasia [1]. Another study showed that, in addition to
improving symptoms associated with BPH, this herb also improved
sexual behavior in men [2]. Although its exact mechanism is
unknown, many researchers speculate that it may work by
inhibiting growth factors responsible for the increase in
prostate size. Another theory is that this herb may have
anti-inflammatory activity in the prostate gland itself.
References (relating to Pygeum africanum):
1. Barlet A, et al. Efficacy of Pygeum africanum
extract in the medical therapy of urination disorders due to
benign prostatic hyperplasia: evaluation of objective and
subjective parameters. A placebo-controlled double-blind
multicenter study. Wien Klin Wocheschr 102:667-673, 1990.
2. Carani C, et al. Urological and sexual evaluation in
the treatment of benign prostatic disease using Pygeum Africanum
at high doses. Arch Ital Urol Nefrol Androl 63:341-345, 1991.
Beta-sitosterol is a plant-derived sterol found in Saw
palmetto and Pygeum Africanum. Studies have shown that the use
of beta-sitosterol has improved urinary tract symptoms
associated with benign prostatic hyperplasia [1]. In addition,
beta-sitosterol inhibits the proliferation of cancer cells in
vitro [2].
References (related to beta-sitosterol):
1. Berges RR, Windeler J, Trampisch HJ, Senge T.
Randomized, placebo-controlled, double blind clinical trials of
beta-sitosterol in patients with benign prostatic hyperplasia.
Beta-sitosterol Study Group. Lancet. 345: 1529-1532, 1995.
2. Awad AB, Chen YC, Fink CS, Hemmessey T. Beta-sitosterol
inhibits HT-29 human colon cancer cell growth and alters
membrane lipids. Anticancer Res 16:2797-2804, 1996.
Stinging nettle (Urtica dioica) is another herb
indigenous to the United States. This herb has been utilized in
Germany for treating both BPH and rheumatoid arthritis. Stinging
nettle has been studied in combination with both Saw palmetto
and Pygeum africanum in the treatment of BPH. When used with Saw
palmetto, improvement in prostate-related urinary problems was
documented [1]. When combined with Pygeum africanum, this herb
diminished the symptoms of BPH. Researchers believe that this
herb's effectiveness is due to its affect on the delivery of
hormones to the prostate gland.
References (related to stinging nettle):
1. Schneider HJ, Honold E, Masuhr T. Treatment of
benign prostatic hyperplasia: Results of a treatment of Sabal
extract WS 1473 and Urtica extract WS 1031 in urologic specialty
practices. Fortschr Med 113:37-40, 1995.
Rye pollen extract does not contain pollen or other
allergens. Rye pollen extract has been shown to be effective in
the treatment of BPH [1,2]. Its action is to inhibit the growth
of prostate cells [3]. The substance in rye pollen extract that
inhibits the growth of prostate cells also inhibits the growth
of prostate cancer cells [4].
References (related to rye pollen extract):
1. Yasumoto R, et al. Clinical evaluation of long-term
treatment using cernitin pollen extract in patients with benign
prostatic hyperplasia. Clin Ther 17:82-87, 1995.
2. Dutkiewiccz S. Usefulness of Cenilton in the
treatment of benign prostatic hyperplasia. Int Urol Nephrol
28:49-53, 1996.
3. Habib FK, et al. Identification of a prostate
inhibitory substance in a pollen extract. Prostate
26(3):133-139,1995.
4. Zhang X, et al. Isolation and characterization of a
cyclic hydroxamic acid from a pollen extract, which inhibits
cancerous cell growth in vitro. J Med Chem 38:735-738, 1995.
Pumpkin seed extract is currently used in Germany for
the treatment of BPH. Animal studies have confirmed its
usefulness in the treatment of BPH [1]. Studies on the effects
of pumpkin seed oil in combination with Saw palmetto have been
conducted, but no studies determining the effects of pumpkin
seed oil alone on BPH have been conducted in men.
References (related to pumpkin seed extract):
1. Zhang X, Ouyang JZ, Zhang YS, Tayalla B, Zhou XC,
Zhou SW. Effect of the extracts of pumpkin seeds on the
urodynamic of rabbits: an experimental study. J Tongji Med Univ,
14(4):235-238, 1994.
Although lycopene has nothing to do with promoting hair
growth, it has been included in Natrecia. Many men will use
Natrecia for prostate health (as well as for hair health).
Lycopene is a powerful anti-carcinogen.
Lycopene is a pigmented substance found in tomatoes and
other fruits and vegetables. Its antioxidant effects may be
protective against prostate cancer. As a carotenoid, it has many
vital health-promoting properties. The carotenoids include
beta-carotene, alpha-carotene, lutein, and beta-cryptoxanthin.
Among the common carotenoids, lycopene is the most efficient
free-radical scavenger [1,2]. This property will be discussed in
greater detail shortly. In addition, it is the predominant
carotenoid found in plasma and in the prostate gland [3,4,5,6].
In a recent article published by the Journal of the
National Cancer Institute, lycopene was shown to be the only
carotenoid to significantly lower the risk of prostate cancer
[7]. In the study, the primary sources of lycopene were
tomato-based. Another beneficial source of lycopene is
strawberries. The lycopene in tomato sauce, however, was most
effective. The higher the intake of cooked tomato products, the
lower the prostate cancer rate. This is probably because tomato
sauce is prepared by cooking ripe tomatoes in an oil-based
medium. This causes lycopene to be placed in a "micellar"
suspension (i.e., within oily droplets) that is easily absorbed
by the body. This is important because lycopene is highly
lipophilic (fat-soluble) and its intestinal absorption is
dependent on this "micellar" suspension. This preparation has
been shown to enhance the absorption of lycopene [8]. This same
study revealed a two to threefold increase in plasma
concentrations of lycopene after ingestion of tomato sauce. In
fact, in the study mentioned above, ingestion of tomato sauce
was the major predictor of plasma lycopene levels [7].
Other studies have shown an inverse relationship
between lycopene ingestion and prostate cancer [9,10].
(“Inverse” means: as one factor is increased, another factor
decreases.) Lycopene probably protects against prostate cancer
by inhibiting the oxidation caused by free radical production.
Free radicals are formed in our bodies when certain fat
molecules react with oxygen. Free radical formation has been
associated with arthritis, hardening of the arteries, and the
development of cancer. Because it is an effective antioxidant,
lycopene is thought to exert protective effects against prostate
cancer. It also happens to be the most abundant carotenoid in
the prostate and is twice as effective as beta-carotene.
Lycopene ingestion has also been shown to lower the risk of
digestive tract cancers.
References (related to lycopene):
1. Di Mascio P, Kaiser S, Sies H. Lycopene as the most
efficient biological carotenoid singlet oxygen quencher. Arch
Biochem Biophys 1989; 274: 532-8.
2. Conn PF, Schlach W, Truscott TG. The singlet oxygen
and carotenoid interaction. J Photochem Photobiol 1991; 11:41-7.
3. Kaplan LA, Stein Ea, Willett Wc, et al. Reference
ranges of retinol, tocopherols, lycopene and alpha- and
beta-carotene in plasma by simultaneous high-performance liquid
chromatographic analysis. Clin Physiol Biochem 1987; 5:297-304.
4. Ascherio A, Stampfer MJ, Colditz Ga, et al.
Correlations of vitamin A and E intakes with the plasma
concentrations of carotenoids and tocopherols among American men
and women. J Nutr 1992;122:1792-801.
5. Stryker WS, Kaplan LA, Stein Ea, et al. The relation
of diet, cigarette smoking and alcohol consumption to plasma
beta-carotene and alpha-tocopherols in diet and plasma. Am J
Epidemiol 1987;45:764-9.
6. Kaplan LA, Lau JM, Stein EA, et al. Carotenoid
composition, concentrations, and relationships in various human
organs. Clin Physiol Biochem 1990;8:1-10.
7. Giovannucci E, Ascherio A, Rimm E, et al. Intake of
Carotenoids and Retinol in Relation to Risk of Prostate Cancer.
J Natl Cancer Inst 1995; 87(23):1767-76
8. Stahl W, Sies H. Uptake of lycopene and its
geometrical isomers is greater from heat- processed than from
unprocessed tomato juice in humans. J Nutr 1992; 122:2161-6.
9. Mills PK, Beeson WL, Phillips RL, et al. Cohort
study of diet, lifestyle, and prostate cancer in Adventist men.
Cancer 1989;64:598-604.
10. Hsing AW, Comstock GW, Abbey H, et al. Serologic
precursors of cancer. J Natl Cancer Inst 1990;82:941-6.
|
WHAT YOU
CAN'T BUY IN A BOTTLE
|
We have always known that diet is important. As
discussed in the book, Conquering Hair Loss, the consumption of
animal fat leads to the production of DHT. Well, guess what? If
DHT is bad for prostate health, then animal fat cannot be good
for the prostate either. Exercise has also been shown to reduce
the risk of prostate cancer.
DIET
A recent study from the Northwestern University School
of Medicine has demonstrated that men who consumed red meat at
least five times weekly had a 2.5 times higher chance of
suffering from prostate cancer than men who consumed red meat
less than once weekly [1]. Another study, performed at Stanford
University School of Medicine, concluded that men who consume
large amounts of saturated fats (more than 45 grams per day)
have a higher risk of developing prostate cancer than men
consuming smaller quantities (less than 22 grams per day) [2].
This study also showed that saturated fats obtained from both
red meats and dairy products were equally dangerous.
References (related to fat consumption):
1. Gann, Peter H., et al. Prospective study of plasma
fatty acids and risk of prostate cancer. Journal of the National
Cancer Institute, Vol. 86, No.4, February 16, 1994, pp.
281-286.
2. Whittemore, Alice S., et al. Prostate cancer in
relation to diet, physical activity, and body size in Blacks,
Whites and Asians in the United States and Canada. Journal of
the National Cancer Institute, Vol. 87, No. 9, May 3, 1995,
pp.652-61.
EXERCISE
A recent report indicates that men with higher
cardiorespiratory fitness levels are four times less likely to
develop prostate cancer than men with low cardiorespiratory
fitness levels [1]. This same study also states that men who are
physically active have a lower incidence of prostate cancer than
men who are less active. These researchers believe exercise
decreases the levels of testosterone, which is a hormone
associated with prostate cancer.
References (related to exercise and prostate cancer):
1. Oliveria, Susan A., et al. The association between
cardiorespiratory fitness and prostate cancer. Medicine and
Science in Sports and Exercise, Vol. 28, No. 1, January 1996,
97-104.
We have discussed many natural agents that reduce the
effects of DHT on the prostate. Natrecia is a completely
natural, vitamin, mineral, and herbal supplement specifically
developed for combating the effects of androgenic alopecia
(i.e., male-pattern baldness). Its formulation is based on a
great deal of research that firmly establishes that these
natural agents can combat the effects of dihydrotestosterone (DHT)
in the treatment of benign prostatic hyperplasia (BPH). Because
many studies have shown that the same culprit, DHT, is
responsible for both male-pattern baldness and benign prostate
enlargement, it is reasonable to expect that Natrecia will be
useful for both conditions. And, these natural agents produce
virtually no side effects.
|